呼吸机下早期雾化吸入布地奈德预防早产儿支气管肺发育不良的疗效观察

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (543 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract

Objective To explore the application value of early atomization inhalation of Budesonide under ventilator in the prevention of bronchopulmonary dysplasia (BPD)in premature infants.Methods The clinical data of 60 premature infants who needed ventilator treatment in Jingdezhen Maternal and Child Health Hospital from January 2020 to January 2023 were retrospectively analyzed.According to the different treatment methods,they were divided into control group (30 cases)and observation group(30 cases).The control group was treated with noninvasive ventilator assisted ventilation,and the observation group was treated with noninvasive ventilator assisted ventilation and early atomization inhalation of Budesonide under ventilator.The occurrence of BPD,treatment effect,pulmonary oxygenation index,inflammatory factors and adverse reactions were compared between the two groups.Results The incidence of BPD in the treatment group was lower than that in the control group,and the total oxygen inhalation time and ventilator use time were shorter than those in the control group,and the differences were statistically significant(P＜0.05).The oxygenation index(OI),alveolar-arterial oxygen partial pressure difference(PA-aO2),arterial partial pressure of carbon dioxide (PaCO2),tumor necrosis factor-α (TNF-α),interleukin(IL) -6,IL-8 and procalcitonin (PCT) in the treatment group were lower than those in the control group after 48 hours of treatment.The arterial partial pressure of oxygen (PaO2)in the observation group was higher than that in the control group,and the difference was statistically significant(P＜0.05).There were no adverse reactions in the two groups during treatment.Conclusion The application of early aerosol inhalation of budesonide under ventilator in premature infants can better improve their lung oxygenation indicators,shorten the total oxygen inhalation time and ventilator use time,reduce the levels of TNF-α,IL-6 and other inflammatory factors,and actively prevent the occurrence of BPD.It is safe and reliable,and has high clinical application value.

Key words： Premature infants Bronchopulmonary dysplasia Ventilator Atomization inhalation of Budesonide Inflammatory factors Pulmonary oxygenation index

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HU Xiaojuan HU Feng DUAN Huiling

Cite this article:

HU Xiaojuan HU Feng DUAN Huiling. Observation on the efficacy of early atomization inhalation of Budesonide under ventilator in the prevention of bronchopulmonary dysplasia in premature infants[J]. 中国当代医药, 2024, 31(16): 73-76转81.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2024/V31/I16/73

[1]	Clauss C，Thomas S，Khodak I，et al.Hydrocortisone and bronchopulmonary dysplasia：variables associated with response in premature infants[J].J Perinatol，2020，40（9）：1349-1357.
[2]	Kwok TC，Sharkey D.Bedside assessment of pulmonary gas exchange in very preterm infants：a pathophysiological approach to bronchopulmonary dysplasia diagnosis?[J].Thorax，2021，76（7）：642-643.
[3]	杨刘，张腾伟，黎巧.维生素D 不同给药时间对极低出生体质量预防早产儿支气管肺发育不良的效果[J].中国优生与遗传杂志，2021，29（3）：355-358.
[4]	刘刚，邝爱玲，谭蔚，等.布地奈德联合多种营养素预防早产儿支气管肺发育不良的疗效观察[J].儿科药学杂志，2021，27（2）：27-31.
[5]	朱曦怡，李福兵.气管内应用布地奈德联合肺表面活性物质预防极早产儿支气管肺发育不良的研究进展[J].医学临床研究，2022，39（6）：801-803.
[6]	Brewer MR，Maffei D，Cerise J，et al.Determinants of the lung microbiome in intubated premature infants at risk for bronchopulmonary dysplasia[J].J Matern Fetal Neonatal Med，2021，34（19）：3220-3226.
[7]	Cuna A，Lagatta JM，Savani RC，et al.Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants[J].Pediatr Pulmonol，2021，56（10）：3283-3292.
[8]	郑小小，胡佩玮，何洁雪，等.早期营养支持联合雾化吸入在支气管肺发育不良患儿中的应用效果[J].中国妇幼保健，2022，37（15）：2802-2805.
[9]	柯琼可，邱莹，甘晓丹，等.布地奈德联合肺表面活性物质治疗胎龄＜32 周早产儿支气管肺发育不良的效果分析[J].中国妇幼保健，2023，38（3）：451-454.
[10]	束辉玲.急性呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J].中国医药科学，2023，13（14）：90-93.
[11]	张雯雯，翁景文，吴丹，等.支气管肺发育不良早产儿血浆miR-15b、VEGF 水平变化及临床意义[J].疑难病杂志，2023，22（4）：414-419.
[12]	陈蒙蒙，郭静，金娟，等.肺泡表面活性物质联合无创高频振荡通气对早产儿支气管肺发育不良患儿血清KL-6、ET-1、SP-A 和TGF-β1水平的影响[J].武汉大学学报（医学版），2021，42（5）：797-801.
[13]	白冬梅，白琼，李妮.布地奈德悬液雾化吸入对新生儿呼吸机相关性肺炎起效时间、CRP 水平及血WBC 的影响[J].贵州医药，2020，44（12）：1873-1874.
[14]	王小亚，薛栋青.布地奈德预防早产儿支气管肺发育不良的临床分析[J].贵州医药，2023，47（5）：751-752.
[15]	牛利美，包志丹，王鲁春，等.早产儿呼吸窘迫综合征早期口服维生素AD 对重度支气管肺发育不良发生情况及炎症因子的影响[J].妇儿健康导刊，2023，2（17）：58-60，69.
[16]	张珂，汪凌燕，仇鹏业,等.新生儿呼吸窘迫综合征早产儿发生支气管肺发育不良的危险因素分析[J].中国当代医药，2023，30（25）：121-126.
[17]	韩素，龚婧娴，王杨.血液学指标联合临床特征对支气管肺发育不良的预测价值[J].妇儿健康导刊，2023，2（11）：7-10，14，封3.
[18]	王耀霜，杨曼，韩萍，等.布地奈德混悬液氧驱雾化吸入法防治早产儿支气管肺发育不良的效果[J].临床和实验医学杂志，2019，18（19）：2121-2124.
[19]	李盼盼，赵武，席康明，等.早期雾化吸入布地奈德混悬液预防早产儿支气管肺发育不良的疗效和安全性分析[J].蚌埠医学院学报，2021，46（6）：755-760.
[20]	黎江，陈铁强，吴敏，等.布地奈德雾化吸入治疗支气管肺发育不良的疗效观察[J].医学临床研究，2020，37（5）：652-654.
[21]	熊昕，谭若锟，陈礼娟，等.接受布地奈德雾化吸入治疗的支气管肺发育不良早产儿骨密度变化观察[J].山东医药，2021，61（18）：57-60.
[22]	刘琳，陈秋芳，付荣，等.早期应用布地奈德对极早产儿支气管肺发育不良的影响[J].新乡医学院学报，2021，38（5）：468-471.
[23]	刘萌萌，吉玲，董梦园，等.布地奈德联合肺表面活性物质气管内给药预防支气管肺发育不良的前瞻性随机对照研究[J].中国当代儿科杂志，2022，24（1）：78-84.
[24]	宗方汝，张晶卉，李文.雾化吸入布地奈德治疗超早早产儿支气管肺发育不良效果观察[J].山东医药，2021，61（6）：10-13.
[25]	徐倩，张顺先，罗立荣，等.布地奈德雾化吸入对早产儿支气管肺发育不良及1 岁时智能发育的影响[J].公共卫生与预防医学，2021，32（2）：77-80.